Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,909 | 2,115 | 99.6% |
| Gift | $59.40 | 1 | 0.2% |
| Education | $51.82 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $4,272 | 298 | $0 (2024) |
| Novo Nordisk Inc | $2,771 | 219 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,443 | 96 | $0 (2024) |
| Lilly USA, LLC | $2,054 | 175 | $0 (2024) |
| ABBVIE INC. | $1,904 | 156 | $0 (2024) |
| Amgen Inc. | $1,664 | 117 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,566 | 103 | $0 (2024) |
| PFIZER INC. | $1,420 | 112 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,375 | 117 | $0 (2023) |
| Merck Sharp & Dohme LLC | $777.64 | 77 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,961 | 147 | PFIZER INC. ($540.36) |
| 2023 | $3,271 | 201 | GlaxoSmithKline, LLC. ($660.18) |
| 2022 | $4,146 | 259 | Novo Nordisk Inc ($712.25) |
| 2021 | $5,076 | 318 | AbbVie Inc. ($425.69) |
| 2020 | $4,033 | 272 | GlaxoSmithKline, LLC. ($582.61) |
| 2019 | $3,342 | 303 | GlaxoSmithKline, LLC. ($480.42) |
| 2018 | $3,842 | 313 | GlaxoSmithKline, LLC. ($639.47) |
| 2017 | $3,348 | 309 | GlaxoSmithKline, LLC. ($613.61) |
All Payment Transactions
2,122 individual payment records from CMS Open Payments — Page 1 of 85
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $103.86 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: VACCINE | ||||||
| 11/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 11/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,427 | 2,577 | $261,535 | $161,564 |
| 2022 | 23 | 1,574 | 2,785 | $282,444 | $173,806 |
| 2021 | 24 | 1,898 | 2,955 | $292,760 | $195,364 |
| 2020 | 20 | 1,839 | 2,656 | $263,308 | $146,889 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 751 | $105,140 | $64,536 | 61.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 279 | 279 | $41,850 | $36,158 | 86.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 336 | 637 | $66,885 | $35,491 | 53.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 70 | $13,440 | $9,625 | 71.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 53 | 74 | $8,288 | $3,258 | 39.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 60 | 60 | $3,000 | $2,362 | 78.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,860 | $2,152 | 75.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,420 | $1,817 | 75.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 37 | 281 | $5,620 | $1,408 | 25.1% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 35 | 40 | $3,280 | $1,363 | 41.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 22 | 24 | $1,440 | $973.20 | 67.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $1,725 | $592.57 | 34.4% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2023 | 37 | 37 | $1,517 | $546.23 | 36.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 12 | $852.00 | $391.92 | 46.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 50 | 69 | $621.00 | $235.29 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 22 | $1,144 | $232.40 | 20.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $363.00 | $178.20 | 49.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 14 | $420.00 | $145.78 | 34.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 34 | 149 | $670.00 | $98.42 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 348 | 799 | $111,860 | $67,524 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 370 | 687 | $72,135 | $38,522 | 53.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 270 | 270 | $40,500 | $35,858 | 88.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 52 | $9,984 | $6,782 | 67.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 29 | 29 | $6,380 | $4,907 | 76.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 50 | 64 | $7,168 | $2,766 | 38.6% |
About Dr. Geoffrey Cox, M.D
Dr. Geoffrey Cox, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700849353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Geoffrey Cox, M.D has received a total of $30,020 in payments from pharmaceutical and medical device companies, with $2,961 received in 2024. These payments were reported across 2,122 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($29,909).
As a Medicare-enrolled provider, Cox has provided services to 6,738 Medicare beneficiaries, totaling 10,973 services with total Medicare billing of $677,623. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 04/06/2006
- Last Updated 07/05/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700849353
Products in Payments
- TRELEGY ELLIPTA (Drug) $2,218
- JARDIANCE (Drug) $1,580
- NURTEC ODT (Drug) $1,231
- Ozempic (Drug) $1,036
- Aimovig (Biological) $884.21
- FARXIGA (Drug) $853.09
- TRULICITY (Drug) $807.20
- TRINTELLIX (Drug) $779.72
- Vascepa (Drug) $750.55
- VRAYLAR (Drug) $685.19
- Rybelsus (Drug) $675.85
- XIFAXAN (Drug) $673.57
- UBRELVY (Drug) $610.49
- Trintellix (Drug) $608.26
- ANORO (Drug) $549.97
- Kerendia (Drug) $544.25
- EMGALITY (Drug) $520.37
- SHINGRIX (Biological) $474.68
- XARELTO (Drug) $471.74
- Saxenda (Drug) $445.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768